This week addressed AI accountability, CPHI award winners, NFC anticounterfeiting, first-in-class FDA approvals, and a shelved FDA voucher pilot lead this week’s roundup.
|Articles|October 2, 2013
- Pharmaceutical Technology-10-02-2013
- Volume 37
- Issue 10
Pharmaceutical Technology, October 2013 Issue (PDF)
Click the title above to open the Pharmaceutical Technology October 2013 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 13 years ago
Q&A with Amie Gehris, Dow Water and Process Solutionsabout 13 years ago
Unraveling the Mystery of Ireland's Pharm-Attractionsabout 13 years ago
Report from: Middle East and North Africaabout 13 years ago
Maintaining and Verifying the Cold Chainabout 13 years ago
Ensuring Compliance with Drug Accountability Requirementsabout 13 years ago
The Expense of Vision in Outsourcingabout 13 years ago
LCMS-8050 Mass Spectrometer Increases Quality Analysisabout 13 years ago
Tracking Quality in Drug Manufacturingabout 13 years ago
USP Seeks Input on Standards for Plastic Packaging Systemsabout 13 years ago
RheocalcT Software Tests Parameters and Data CollectionAdvertisement
Related to this article
Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
Gloveless isolators don’t end interventions. Learn to assess intervention dependency in robotic aseptic filling and when glove ports are justified.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
France Remains One of Europe’s Leading Biotech Funding Hubs
3
Our Biggest Takeaways From AAPS PharmSci 360
4
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
5